Learn more about the importance of imaging from nationally known amyloidosis expert, Dr. Ahmad Masri. A heart specialist and leader of OHSU’s Cardiac Amyloidosis and Hypertrophic Cardiomyopathy programs, Dr. Masri discussed how imaging plays a key role in identifying amyloidosis and monitoring treatment.
Original Presentation Date:
February 25, 2026
0:00 — Welcome
3:25 — Introduction
5:21 — Why Imaging in Amyloidosis is Complicated
6:37 — Echocardiography
11:18 — Global Longitudinal Strain
14:44 — Cardiac MRI
24:01 — Bone Scintigraphy
33:47 — Patient Example
38:59 — How do we monitor patients?
45:35 — Conclusions
47:22 — FAQ Session
47:29 — What is the best imaging method to monitor progression of hereditary amyloidosis?
49:07 — How often should imaging be repeated after diagnosis?
50:42 — Is a heart biopsy required after a cardiac MRI to properly diagnose amyloidosis?
52:20 — Why would my doctor perform a saliva test during my amyloidosis diagnosis process?
53:14 — Can a PYP test determine ATTR-CM?
54:01 — Was Dr. John Wall involved in Dr. Masri’s images from OHSU?
55:05 — How could amyloid deposits in the shoulder be detected?
55:44 — Can cardiac MRI be used to track progression of amyloidosis?
56:36 — How does imaging impact treatment choices?
57:38 — Is amyloidosis becoming more common do we just have better diagnostic tools?
58:21 — Conclusion
Contact ARC:
Call +1 (617) 467-5170
Email ARC at support@arci.org

